why choose us

First received: May 28, 2024

Clinical Trial: A Bioequivalence Study of Two Different Dosage Form of Genakumab

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gouty Arthritis (GA)

Study Type: INTERVENTIONAL


Official Title: A Single Center, Randomized, Double-blind, Single Dose Bioequivalence Trial of Genakumab in Chinese Healthy Male Adults

Brief Summary: The purpose of this study is to investigate whether Genakumab Injection is bioequivalent to Genakumab for Injection.

Read more